Search by Drug Name or NDC

    NDC 59148-0010-13 ABILIFY 20 mg/1 Details

    ABILIFY 20 mg/1

    ABILIFY is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is ARIPIPRAZOLE.

    Product Information

    NDC 59148-0010
    Product ID 59148-010_54fce3dd-d985-44ac-a5d8-d44be28fb2fa
    Associated GPIs 59250015000340
    GCN Sequence Number 051335
    GCN Sequence Number Description aripiprazole TABLET 20 MG ORAL
    HIC3 H7X
    HIC3 Description ANTIPSYCHOTICS, ATYP, D2 PARTIAL AGONIST/5HT MIXED
    GCN 18539
    HICL Sequence Number 024551
    HICL Sequence Number Description ARIPIPRAZOLE
    Brand/Generic Brand
    Proprietary Name ABILIFY
    Proprietary Name Suffix n/a
    Non-Proprietary Name ARIPIPRAZOLE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name ARIPIPRAZOLE
    Labeler Name Otsuka America Pharmaceutical, Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021436
    Listing Certified Through 2024-12-31

    Package

    NDC 59148-0010-13 (59148001013)

    NDC Package Code 59148-010-13
    Billing NDC 59148001013
    Package 30 TABLET in 1 BOTTLE, PLASTIC (59148-010-13)
    Marketing Start Date 2002-11-15
    NDC Exclude Flag N
    Pricing Information N/A